SCHEMBL6538129

SCHEMBL6538129

Cc1cnc2c(N)ccc(Cl)c2c1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.35
PRKCI P41743 1/20 0.35
CYP3A4 P08684 2/20 0.34
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
CD44 P16070 1/20 0.32
NOS3 P29474 2/20 0.31
NOS2 P35228 2/20 0.31
NOS1 P29475 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
UHRF1 Q96T88 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
NR4A2 P43354 1/20 0.30
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538359 0.87 CYP3A4 (0.39) AXLPRKCICYP3A4CCR1CCR5
SCHEMBL6537397 0.73 ALDH1A1 (0.48) CYP3A4KDM4EMEN1KMT2AALDH1A1
SCHEMBL6537500 0.73 NR4A2 (0.41) CYP3A4CCR1CCR5CCR8KDM4E
SCHEMBL6538159 0.71 TDP1 (0.46) AXLPRKCICYP3A4CCR1CCR5
SCHEMBL31565251 0.71 NR4A2 (0.46) CYP3A4KDM4EMEN1KMT2AALDH1A1
SCHEMBL6537373 0.71 NR4A2 (0.46) CYP3A4KDM4EMEN1KMT2AALDH1A1
SCHEMBL437482 0.69 CYP3A4 (0.35) CYP3A4CCR1CCR5CCR8KDM4E
SCHEMBL11637772 0.68 KDM4E (0.50) KDM4EPOLBCD44KMT2AALDH1A1
SCHEMBL6537704 0.67 LMNA (0.42) CYP3A4KDM4E
SCHEMBL436747 0.66 CYP3A4 (0.32) CYP3A4KDM4EPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed